1. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. Understanding vaccines: what they are, how they work. National Institute of Allergy and Infectious Diseases Website. http://www.niaid.nih.gov/topics/vaccines/documents/undvacc.pdf. Published January 2008. Accessed March 24, 2015. .
2. Hagensee ME, Yaegashi N, Galloway GA. Self-assembly of human papilloma virus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol . 1993;67(1):315-322.
3. American Cancer Society. Anti-angiogenesis treatment. American Cancer Society Website. http://www.cancer.org/acs/groups/cid/documents/webcontent/002988-pdf.pdf. Revised March 10, 2009. Accessed March 24, 2015.
4. Gambacorti-Passerini CB, Gunby RH, Piazza R, Galietta A, Rostagno R, Scapozza L. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosomepositive leukaemias. Lancet Oncol . 2003;4(2):75-85.
5. Hudis CA. Trastuzumab—mechanism of action and use in clinical practice. N Engl J Med . 2007;357(1):39-51.
6. NPI reference guide on vaccines and vaccine safety: How vaccines work. PATH Website. http://www.path.org/vaccineresources/files/How_Vaccines_Work.pdf. Accessed March 24, 2015.
7. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet . 1981;318(8256):1129-1133.
8. Vik-Mo EO, Nyakas M, Mikkelsen BV, et al. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother . 2013;62(9):1499-1509.
9. Kantoff PW, Higano CS, Shore ND, et al; IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med . 2010;363(5):411-422.
10. Gulley JL, Madan RA, Tsang KY, et al. Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer. Cancer Immunol Res . 2014;2(2):133-141.
11. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC. Humoral response to a viral glycan correlates with survival on PROSTVAC VF. Proc Natl Acad Sci USA . 2014;111(17):E1749-E1758.
12. Public Health England. Immunity and how vaccines work: The green book, chapter 1. GOV.UK Website. https://www.gov.uk/government/publications/immunity-and-how-vaccines-work-the-green-book-chapter-1. Published March 19, 2013. Accessed March 24, 2015.
13. Walter S, Weinschenk T, Stenzl A, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med . 2012;18(8):1254-1261.
14. Ottenhausen M, Bodhinayake I, Banu M, Kesavabhotla K, Ray A, Boockvar JA. Industry progress report on neuro-oncology: biotech update 2013. J Neurooncol . 2013;115(2):311-316.
